Comparison of Bleeding Risk Between Rivaroxaban and Apixaban: The Pilot Study
Clinical trial NCT02559856 · COMPLETED
Trial details
- NCT number
- NCT02559856
- Sponsor
- Ottawa Hospital Research Institute
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-01
- Primary completion
- 2017-11-01
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.